Sorrento Gets OK For $2M Ch. 11 Funding Infusion, Asset Sale

By Emlyn Cameron · March 8, 2024, 7:56 PM EST

A Texas bankruptcy judge on Friday approved drug developer Sorrento Therapeutics Inc.'s bid for an asset sale and $2 million in funds to fuel its Chapter 11 case, saying they represented...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Agenda

Case Information

Case Title

Sorrento Therapeutics, Inc.

Case Number

Court

Texas Southern

Nature of Suit

Date Filed

February 13, 2023

Recent Articles By Emlyn

November 04, 2024
Meet The Attys Behind Biotech Co. Gritstone's Ch. 11
August 23, 2024
Clinic Biz Can Tap Additional Ch. 11 Lifeline, Judge Says
June 28, 2024
Cano Health Wins Ch. 11 Plan Confirmation
May 21, 2024
Cano Judge Agrees To OK Ch. 11 Plan Disclosure Statement
May 07, 2024
Meet The Weil Attys Guiding Steward Health's Ch. 11
April 25, 2024
3rd Circ. Lets Mallinckrodt Off Sanofi's Royalty Hook
April 10, 2024
Bankrupt Hospital Co.'s $16M Deal With Ex-Execs OK'd
April 04, 2024
Judge Denies New Official Committee In Talc Ch. 11
March 11, 2024
Judge OKs Eye Care Tech Co.'s $8M DIP Request
March 04, 2024
Sorrento Creditors Fight To Keep Ch. 11 In Texas